{
  "id": "resp_0f5acc2f159de05a00693c9590b42c8195859cd3ea0e59255d",
  "object": "response",
  "created_at": 1765578128,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_0f5acc2f159de05a00693c9590fa1c8195a1d1d361397e7fb5",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c9593540c8195b6b01f78b3cd4b8c",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "CDK12 inhibitor triple-negative breast cancer patent WO"
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c95953b6881958849db93456cc12e",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c95972cf481958ee22cef92ea228f",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "WO SR-4835 CDK12 CDK13 inhibitor patent"
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c9599382481958262b345507a0051",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c959e1fec8195a57943a5fc5c455b",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "site:patents.google.com WO CDK12 \"triple-negative\""
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c95a06ae481958a85a63dca3ef4f9",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c95aa5404819594050ad4a989cd80",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://patents.google.com/patent/WO2019217421A1/en"
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c95ab77548195ab8bf225cc6e11b5",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c95ad92648195a0f34fa45cc9ca79",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "find_in_page",
        "pattern": "cdk12",
        "url": "https://patents.google.com/patent/WO2019200214A1/en"
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c95af00a08195bbadba6a7a6f303e",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c95b7645c8195af87b56733e548e4",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://patents.google.com/patent/WO2019200214A1/en"
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c95b8f9e881958ccf6f6ba6beca25",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0f5acc2f159de05a00693c95c409c08195a93a0370b4e7cb2b",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "find_in_page",
        "pattern": "PCT/US16/055436",
        "url": "https://patents.google.com/patent/WO2019217421A1/en"
      }
    },
    {
      "id": "rs_0f5acc2f159de05a00693c95c5e9208195ab449529fa5d447d",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_0f5acc2f159de05a00693c95ded2e48195802b9c1138223787",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [
            {
              "type": "url_citation",
              "end_index": 368,
              "start_index": 293,
              "title": "WO2019217421A1 - Small molecule inhibitors of cdk12/cdk13 \n        - Google Patents",
              "url": "https://patents.google.com/patent/WO2019217421A1/en"
            },
            {
              "type": "url_citation",
              "end_index": 567,
              "start_index": 492,
              "title": "WO2019217421A1 - Small molecule inhibitors of cdk12/cdk13 \n        - Google Patents",
              "url": "https://patents.google.com/patent/WO2019217421A1/en"
            },
            {
              "type": "url_citation",
              "end_index": 757,
              "start_index": 682,
              "title": "WO2019217421A1 - Small molecule inhibitors of cdk12/cdk13 \n        - Google Patents",
              "url": "https://patents.google.com/patent/WO2019217421A1/en"
            },
            {
              "type": "url_citation",
              "end_index": 1133,
              "start_index": 1058,
              "title": "WO2019200214A1 - Compositions and methods for treating cancer \n        - Google Patents",
              "url": "https://patents.google.com/patent/WO2019200214A1/en"
            },
            {
              "type": "url_citation",
              "end_index": 1248,
              "start_index": 1173,
              "title": "WO2019200214A1 - Compositions and methods for treating cancer \n        - Google Patents",
              "url": "https://patents.google.com/patent/WO2019200214A1/en"
            },
            {
              "type": "url_citation",
              "end_index": 1676,
              "start_index": 1588,
              "title": "Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/31668947/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 1834,
              "start_index": 1746,
              "title": "Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/31668947/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 2333,
              "start_index": 2245,
              "title": "Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/34864331/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 2559,
              "start_index": 2471,
              "title": "Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/34864331/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 3094,
              "start_index": 3006,
              "title": "Discovery of a novel dual-target inhibitor of CDK12 and PARP1 that induces synthetic lethality for treatment of triple-negative breast cancer - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/37478560/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 3267,
              "start_index": 3179,
              "title": "Discovery of a novel dual-target inhibitor of CDK12 and PARP1 that induces synthetic lethality for treatment of triple-negative breast cancer - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/37478560/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 3795,
              "start_index": 3707,
              "title": "CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/27880910/?utm_source=openai"
            },
            {
              "type": "url_citation",
              "end_index": 4003,
              "start_index": 3915,
              "title": "CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer - PubMed",
              "url": "https://pubmed.ncbi.nlm.nih.gov/27880910/?utm_source=openai"
            }
          ],
          "logprobs": [],
          "text": "- **Title:** WO2019217421A1 - Small molecule inhibitors of cdk12/cdk13 (Google Patents)  \n  - **URL:** `https://patents.google.com/patent/WO2019217421A1/en`  \n  - **Direct quote snippets (identifiers / targets / modality / indication):**\n    - “WO2019217421A1 PCT/US2019/031116 US2019031116W” ([patents.google.com](https://patents.google.com/patent/WO2019217421A1/en))  \n    - “CDK12 mutations have been reported in many cancers such as breast cancer including triple negative breast cancer” ([patents.google.com](https://patents.google.com/patent/WO2019217421A1/en))  \n    - “Reference is made to PCT/US16/055436, filed Oct. 5, 2016, and published as W017/066,055, Apr. 20, 2017,” ([patents.google.com](https://patents.google.com/patent/WO2019217421A1/en))  \n\n- **Title:** WO2019200214A1 - Compositions and methods for treating cancer (Google Patents)  \n  - **URL:** `https://patents.google.com/patent/WO2019200214A1/en`  \n  - **Direct quote snippets (identifiers / targets / modality / indication):**\n    - “WO2019200214A1 PCT/US2019/027160 US2019027160W” ([patents.google.com](https://patents.google.com/patent/WO2019200214A1/en))  \n    - “Prior art keywords     cdk12” ([patents.google.com](https://patents.google.com/patent/WO2019200214A1/en))  \n\n- **Title:** Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer (PubMed)  \n  - **URL:** `https://pubmed.ncbi.nlm.nih.gov/31668947/`  \n  - **Direct quote snippets (identifiers / targets / modality / indication):**\n    - “Here we report the development of SR-4835, a highly selective dual inhibitor of CDK12 and CDK13” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31668947/?utm_source=openai))  \n    - “which disables triple-negative breast cancer (TNBC) cells.” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31668947/?utm_source=openai))  \n\n- **Title:** Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor (PubMed)  \n  - **URL:** `https://pubmed.ncbi.nlm.nih.gov/34864331/`  \n  - **Direct quote snippets (identifiers / targets / modality / indication):**\n    - “we have synthesized a potent PROTAC degrader PP-C8 based on the noncovalent dual inhibitors of CDK12/13” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34864331/?utm_source=openai))  \n    - “PP-C8 demonstrates profound synergistic antiproliferative effects with PARP inhibitor in triple-negative breast cancer (TNBC).” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34864331/?utm_source=openai))  \n\n- **Title:** Discovery of a novel dual-target inhibitor of CDK12 and PARP1 that induces synthetic lethality for treatment of triple-negative breast cancer (PubMed)  \n  - **URL:** `https://pubmed.ncbi.nlm.nih.gov/37478560/`  \n  - **Direct quote snippets (identifiers / targets / modality / indication):**\n    - “The new dual-target inhibitor (12e) showed potent inhibitory activity against CDK12 (IC_{50} = 285 nM) and PARP1 (IC_{50} = 34 nM)” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37478560/?utm_source=openai))  \n    - “Keywords: CDK12; Dual-target inhibitor; PARP1; Synthetic lethality; TNBC.” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37478560/?utm_source=openai))  \n\n- **Title:** CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer (PubMed)  \n  - **URL:** `https://pubmed.ncbi.nlm.nih.gov/27880910/`  \n  - **Direct quote snippets (identifiers / targets / modality / indication):**\n    - “dinaciclib, an inhibitor of cyclin-dependent kinases (CDKs) 1, 2, 5, and 9, additionally has potent activity against CDK12” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/27880910/?utm_source=openai))  \n    - “In BRCA-mutated triple-negative breast cancer (TNBC) cells and patient-derived xenografts (PDXs), dinaciclib” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/27880910/?utm_source=openai))"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "medium",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 34322,
    "input_tokens_details": {
      "cached_tokens": 4352
    },
    "output_tokens": 5909,
    "output_tokens_details": {
      "reasoning_tokens": 4883
    },
    "total_tokens": 40231
  },
  "user": null,
  "metadata": {}
}